Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9796725
SERIAL NO

15488800

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formula I:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA 541-0045

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Afroze, Roushan Lexington, US 4 25
Bharathan, Indu T Cambridge, US 15 45
Ciavarri, Jeffrey P Reading, US 15 134
Fleming, Paul E Natick, US 37 237
Gaulin, Jeffrey L Londonderry, US 4 25
Girard, Mario Waltham, US 22 253
Langston, Steven P N. Andover, US 29 320
Soucy, Francois Stoneham, US 35 178
Wong, Tzu-Tshin Belmont, US 13 46
Ye, Yingchun Belmont, US 16 48

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 24, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 24, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00